Monograph 30 · ERD-INJ-29
Retatrutide Dual Chamber
A dual-chamber pen — 10 mg once weekly.
The same retatrutide — a once-weekly triple agonist at the GLP-1, GIP and glucagon receptors — in a dual-chamber pen. The two chambers are combined in the device before the first injection, and the pen is then labelled to deliver 10 mg per dose.
The pen holds 30 mg. The carton contains that one dual-chamber pen and 10 disposable needles, and it is serialised for export. Keep it refrigerated, do not freeze it, and use a new needle for every injection.
- INN
- Retatrutide
- Class
- Triple agonist · GLP-1, GIP and glucagon receptors
- Category
- Pens
- Form
- Solution for injection, pen
- Strength
- 30 mg
- Pack
- 1 dual-chamber pen · 10 needles
- GTIN
- 05012345678930
Each dual-chamber pen contains retatrutide 30 mg as a solution for injection, labelled to deliver 10 mg per dose, once weekly. The two chambers are combined in the pen before the first dose. The carton contains 1 pen and 10 disposable needles.
For patients
Package leaflet →
The plain-language leaflet from inside the pack.
For healthcare professionals
Product information →
The full document in SmPC order, ready to print.
Ergopharm Advanced Research Centre, Tandalja, Vadodara, Gujarat 390012, India. For Export Only. All products are prescription-only and for use under medical supervision.